Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
vonoprazan + amoxicillin + tripotassium dicitrate bismuthate
- Development stage
- Unknown
- Lead developer
- Takeda
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
This appears to be a combination of vonoprazan (a potassium-competitive acid blocker), amoxicillin (an antibiotic), and tripotassium dicitrate bismuthate (a bismuth salt). However, based on the search results, this specific triple combination is not documented as a single formulation. The search results discuss vonoprazan-amoxicillin dual therapy compared to bismuth-containing quadruple therapy as separate treatment approaches for Helicobacter pylori infection.
- Other names
- Bismuth/Amoxicillin/PCAB Triple TherapyBismuth amoxicillin potassiumBismuth amoxilillin potassiumBismuth + amoxicillin potassium-Kaohsiung Medical University-Helicobacter pylori infection
02
Targets
PBP (Penicillin-binding protein family)ATP4A (Potassium–transporting ATPase alpha chain 1)
Beyond the preview
Go deeper on vonoprazan + amoxicillin + tripotassium dicitrate bismuthate.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on vonoprazan + amoxicillin + tripotassium dicitrate bismuthate.